Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-ca3-15-03475/USCOURTS-ca3-15-03475-1/pdf.json

Nature of Suit Code: 410
Nature of Suit: Antitrust
Cause of Action: 

---

UNITED STATES COURT OF APPEALS

FOR THE THIRD CIRCUIT 

_____________

No. 15-3475

_____________

IN RE: MODAFINIL ANTITRUST LITIGATION

Mylan Laboratories, Inc.; Mylan Pharmaceuticals Inc.; 

Ranbaxy Laboratories, Ltd; Ranbaxy Pharmaceuticals, Inc.,

 Appellants 

______________

 

On Appeal from the United States District Court

for the Eastern District of Pennsylvania

District Court No. 2-06-cv-01797

District Judge: The Honorable Mitchell S. Goldberg

_________________

Before: SMITH, JORDAN, and RENDELL, Circuit Judges

_________________ 

ORDER AMENDING OPINION

_________________ 

The opinion filed September 13, 2016 is amended solely as to the listing of Paul 

B. Hewitt, Esq. and Catherine Creely, Esq. on the opinion and not as to the substance of 

the opinion itself. Mr. Hewitt and Ms. Creely should have been listed as members of 

Akin Gump Strauss Hauer & Feld in Washington, DC. Mr. Hewitt was omitted from the 

listing of counsel and Ms. Creely was erroneously listed as a member of Cohn & Marks 

in Washington, DC. The opinion is amended as follows:

Case: 15-3475 Document: 003112422330 Page: 1 Date Filed: 09/29/2016
Paul B. Hewitt

C. Fairley Spillman

Catherine E. Creely

Akin Gump Strauss Hauer & Feld

1333 New Hampshire Avenue, N.W.

Suite 400

Washington, DC 20036

For the Court,

Marcia M. Waldron, Clerk

Date: September 29, 2016

PDB/cc: All Counsel of Record

Case: 15-3475 Document: 003112422330 Page: 2 Date Filed: 09/29/2016